vs
CRYO CELL INTERNATIONAL INC（CCEL）与Quipt Home Medical Corp.（QIPT）财务数据对比。点击上方公司名可切换其他公司
Quipt Home Medical Corp.的季度营收约是CRYO CELL INTERNATIONAL INC的6.2倍（$49.0M vs $7.8M）。Quipt Home Medical Corp.净利率更高（-2.1% vs -48.7%，领先46.5%）。Quipt Home Medical Corp.同比增速更快（32.3% vs -2.3%）。Quipt Home Medical Corp.自由现金流更多（$6.9M vs $1.2M）
Cryo-Cell国际是一家脐带血库企业，由丹·理查德于1989年创立，是全球首家分离并储存干细胞的民营脐带血库，总部位于佛罗里达州奥兹马尔，地处坦帕市郊。
Quipt Home Medical Corp是一家总部位于美国的家用医疗设备服务商，主营呼吸护理、睡眠治疗用品及慢性病管理相关医疗产品，面向慢性病患者群体提供服务，合作方涵盖医疗机构与保险支付机构。
CCEL vs QIPT — 直观对比
营收规模更大
QIPT
是对方的6.2倍
$7.8M
营收增速更快
QIPT
高出34.5%
-2.3%
净利率更高
QIPT
高出46.5%
-48.7%
自由现金流更多
QIPT
多$5.7M
$1.2M
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $7.8M | $49.0M |
| 净利润 | $-3.8M | $-1.1M |
| 毛利率 | 77.9% | 53.5% |
| 营业利润率 | -50.6% | 2.1% |
| 净利率 | -48.7% | -2.1% |
| 营收同比 | -2.3% | 32.3% |
| 净利润同比 | -105.1% | 2.9% |
| 每股收益（稀释后） | $-0.46 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCELQIPT
| Q4 25 | $7.8M | $49.0M | ||
| Q3 25 | $7.8M | $39.8M | ||
| Q2 25 | $7.9M | $35.1M | ||
| Q1 25 | $8.0M | $33.3M | ||
| Q4 24 | $8.0M | $37.1M | ||
| Q3 24 | $8.1M | — | ||
| Q2 24 | $8.0M | — | ||
| Q1 24 | $7.9M | — |
净利润CCELQIPT
| Q4 25 | $-3.8M | $-1.1M | ||
| Q3 25 | $749.4K | $-3.5M | ||
| Q2 25 | $355.8K | $-3.0M | ||
| Q1 25 | $282.9K | $-3.0M | ||
| Q4 24 | $-1.9M | $-1.1M | ||
| Q3 24 | $1.1M | — | ||
| Q2 24 | $655.8K | — | ||
| Q1 24 | $556.2K | — |
毛利率CCELQIPT
| Q4 25 | 77.9% | 53.5% | ||
| Q3 25 | 77.0% | 48.7% | ||
| Q2 25 | 76.6% | 57.6% | ||
| Q1 25 | 75.1% | 54.6% | ||
| Q4 24 | 78.4% | 52.1% | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | 73.7% | — |
营业利润率CCELQIPT
| Q4 25 | -50.6% | 2.1% | ||
| Q3 25 | 24.3% | -3.6% | ||
| Q2 25 | 18.8% | -5.2% | ||
| Q1 25 | 13.3% | -3.0% | ||
| Q4 24 | -1.5% | 1.2% | ||
| Q3 24 | 17.2% | — | ||
| Q2 24 | 17.3% | — | ||
| Q1 24 | 10.5% | — |
净利率CCELQIPT
| Q4 25 | -48.7% | -2.1% | ||
| Q3 25 | 9.6% | -8.9% | ||
| Q2 25 | 4.5% | -8.6% | ||
| Q1 25 | 3.5% | -9.1% | ||
| Q4 24 | -23.2% | -2.9% | ||
| Q3 24 | 13.0% | — | ||
| Q2 24 | 8.2% | — | ||
| Q1 24 | 7.1% | — |
每股收益（稀释后）CCELQIPT
| Q4 25 | $-0.46 | $-0.02 | ||
| Q3 25 | $0.09 | $-0.07 | ||
| Q2 25 | $0.04 | $-0.07 | ||
| Q1 25 | $0.03 | $-0.07 | ||
| Q4 24 | $-0.23 | $-0.03 | ||
| Q3 24 | $0.13 | — | ||
| Q2 24 | $0.08 | — | ||
| Q1 24 | $0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $10.5M |
| 总债务越低越好 | $8.4M | $84.0M |
| 股东权益账面价值 | $-18.6M | $113.0M |
| 总资产 | $61.7M | $280.7M |
| 负债/权益比越低杠杆越低 | — | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资CCELQIPT
| Q4 25 | $3.3M | $10.5M | ||
| Q3 25 | $3.2M | $12.9M | ||
| Q2 25 | $4.4M | $11.3M | ||
| Q1 25 | $3.5M | $17.1M | ||
| Q4 24 | $3.5M | $15.5M | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $979.6K | — |
总债务CCELQIPT
| Q4 25 | $8.4M | $84.0M | ||
| Q3 25 | $8.4M | $87.6M | ||
| Q2 25 | $8.4M | $66.0M | ||
| Q1 25 | $8.5M | $71.5M | ||
| Q4 24 | $8.5M | $70.6M | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.6M | — |
股东权益CCELQIPT
| Q4 25 | $-18.6M | $113.0M | ||
| Q3 25 | $-14.8M | $112.1M | ||
| Q2 25 | $-15.6M | $102.5M | ||
| Q1 25 | $-14.7M | $103.6M | ||
| Q4 24 | $-13.2M | $106.3M | ||
| Q3 24 | $-9.6M | — | ||
| Q2 24 | $-10.7M | — | ||
| Q1 24 | $-10.3M | — |
总资产CCELQIPT
| Q4 25 | $61.7M | $280.7M | ||
| Q3 25 | $63.2M | $283.3M | ||
| Q2 25 | $64.4M | $236.1M | ||
| Q1 25 | $64.4M | $244.6M | ||
| Q4 24 | $64.7M | $242.8M | ||
| Q3 24 | $62.9M | — | ||
| Q2 24 | $62.6M | — | ||
| Q1 24 | $61.7M | — |
负债/权益比CCELQIPT
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3M | $8.9M |
| 自由现金流经营现金流 - 资本支出 | $1.2M | $6.9M |
| 自由现金流率自由现金流/营收 | 15.5% | 14.0% |
| 资本支出强度资本支出/营收 | 0.9% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.2M | $26.6M |
8季度趋势，按日历期对齐
经营现金流CCELQIPT
| Q4 25 | $1.3M | $8.9M | ||
| Q3 25 | $2.5M | $9.8M | ||
| Q2 25 | $707.0K | $9.7M | ||
| Q1 25 | $954.1K | $8.9M | ||
| Q4 24 | $2.2M | $9.3M | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $-356.9K | — |
自由现金流CCELQIPT
| Q4 25 | $1.2M | $6.9M | ||
| Q3 25 | $2.5M | $8.0M | ||
| Q2 25 | $644.6K | $4.4M | ||
| Q1 25 | $892.0K | $7.3M | ||
| Q4 24 | $2.1M | $5.6M | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $21.5K | — | ||
| Q1 24 | $-814.6K | — |
自由现金流率CCELQIPT
| Q4 25 | 15.5% | 14.0% | ||
| Q3 25 | 31.9% | 20.0% | ||
| Q2 25 | 8.1% | 12.6% | ||
| Q1 25 | 11.2% | 22.0% | ||
| Q4 24 | 26.8% | 15.2% | ||
| Q3 24 | 27.9% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -10.4% | — |
资本支出强度CCELQIPT
| Q4 25 | 0.9% | 4.2% | ||
| Q3 25 | 0.5% | 4.6% | ||
| Q2 25 | 0.8% | 14.9% | ||
| Q1 25 | 0.8% | 4.8% | ||
| Q4 24 | 0.1% | 9.9% | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 21.8% | — | ||
| Q1 24 | 5.8% | — |
现金转化率CCELQIPT
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | -0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
